BJUI Mini Reviews - Prostate cancer immunology – an update for urologists

BERKELEY, CA (UroToday.com) - Prostate cancer (CaP) is the most prevalent non-skin malignancy in males in the western world.

In the United States it is estimated that 192,280 men were newly diagnosed with CaP and 27,360 died from the disease in 2009.
The purpose of this article is to concisely review the growing body of evidence suggesting an immunity-based link between CaP and inflammation and infection.

Prostatitis can be associated with infection (acute or chronic bacterial infections) or inflammation with no evidence of infection (abacterial prostatitis/chronic pelvic pain syndrome). ...View or save the Mini Review as a .pdf file

 

 

 

 

Nieroshan Rajarubendra,* Nathan Lawrentschuk, Damien M. Bolton,* Laurence Klotz, and Ian D. Davis†§

*Department of Surgery, University of Melbourne, Austin Hospital, Urology Unit, Uro-Oncology Laboratory, Ludwig Institute for Cancer Research, §Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, VIC, Australia, and Department of Urology, University of Toronto, Sunnybrook Hospital, Toronto. ON, Canada

 



More BJUI Mini Reviews and Archives



email news signup